Cell‐free long non‐coding RNAs (lncRNAs) are stably present in urine and can serve as
non‐invasive biomarkers for cancer. We aimed to identify signatures of lncRNAs in urine for …

Accumulating evidence indicates that long non-coding RNAs (lncRNAs) play important roles
in tumorigenesis and progression. We aimed to identify a panel of lncRNAs for the diagnosis …

Abstract Introduction Long non-coding RNAs (lncRNAs) have fundamental roles in cell
migration, proliferation, invasion and metastasis. Methods In the current study, we evaluated …

Dysregulation of long noncoding RNAs (lncRNAs) has been regarded as a primary feature
of several human cancers. However, the genome‑wide expression and functional …

Long noncoding RNAs (lncRNAs) have been implicated playing important roles in human
urologic cancers. In the present study, microarray analysis was initially performed to screen …

Abstract Background/Aims: Bladder cancer (BC) is one of the most frequent urologic tumors
worldwide. However, long non-coding RNA (lncRNA) expression profiles in BC progression …

Bladder cancer (BC) is the most common malignant tumor in the urinary system, and its early
diagnosis is conducive to improving clinical prognosis and prolonging overall survival time …

Purpose: Loss of epigenetic gene regulation through altered long noncoding RNA (lncRNA)
expression seems important in human cancer. LncRNAs have diagnostic and therapeutic …

Background: Increasing evidence shows that dysregulated expression of long non-coding
RNAs (lncRNAs) can serve as diagnostic or prognostic markers in bladder cancer. The aim …

Several reports over the last 10 years provided evidence that long noncoding RNAs
(lncRNAs) are often altered in bladder cancers. lncRNAs are longer than 200 nucleotides …